Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
43 hedge funds and large institutions have $10.5M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 41 → 43 (+2)
10% less capital invested
Capital invested by funds: $11.6M → $10.5M (-$1.12M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$174K |
| 2 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$98K |
| 3 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$18.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.1K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$13.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$518K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$112K |
| 3 |
SIM
Spark Investment Management
New York
|
-$55.4K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$38.1K |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$13.8K |
FRTX Hedge Fund Activity: Q1 2016 in Review
43 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2016, worth a combined $10.5M — down 9.6% from $11.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FRTX positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $174K. The largest seller was Ariel Investments, cutting an estimated $518K.
- 43 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2016, up from 41 in Q4 2015.
- Funds reported $10.5M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2016, down 9.6% quarter-over-quarter.
- 5 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2016 and 3 closed out, a net change of +2 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2016 was Renaissance Technologies, an estimated $174K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2016 was Ariel Investments, an estimated $518K sold.
Based on aggregated 13F filings for Q1 2016.